Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
The Latest on: Pain medications
via Google News
The Latest on: Pain medications
- Can a mouthwash relieve oral mucositis pain? on April 18, 2019 at 12:13 am
"The mean differences in pain reduction by the area under the curve for both treatment intervention mouthwashes were less than the minimal clinically important difference of 3.5 points," the authors ... […]
- Back Pain Treatment Using Chiropractic Care on April 17, 2019 at 9:45 pm
(MENAFN - Market Press) Do You Have Returning Pain? Back pain is very a common trouble. Just about, everyone has most likely faced back pain one time or the. It could be because of different ... […]
- Nocion launches with $27M and 'charged drugs' to selectively target pain on April 17, 2019 at 7:00 am
It’s a familiar story—you need a cavity filled, so the dentist gives you a local anesthetic before she starts drilling. Hours later, you’re biting into your cheek or drooling on yourself because your ... […]
- Older Adults’ Perceptions Of Opioid-Related Policies And What They Mean For Pain Treatment on April 17, 2019 at 5:14 am
Pain is everywhere. In the United States, nearly 66 million individuals experience acute pain from a surgery or procedure each year, and 100 million individuals suffer from chronic pain lasting weeks ... […]
- This Low-Tech Tool Is a Remarkably Effective Treatment for Back Pain Relief on April 16, 2019 at 11:11 am
The Plexus Wheel+ is comprised of three separate wheels of varying size, all of which are designed to provide you with a customized level of pressure (12 inch for “gentle,” 10 inch for “medium,” and 6 ... […]
- Learn About Minimally Invasive Treatment Options for Back Pain at Silver Cross on April 16, 2019 at 9:05 am
Oh, our aching backs! Over a lifetime - 80 percent of us will experience an episode of back pain or discomfort. It's the second most common reason we visit the doctor or miss work, next to the common ... […]
- The Growing Prevalence of Chronic Pain is Driving the Global Opioids Drugs Market at a CAGR of 2.52% by 2027 on April 16, 2019 at 8:36 am
Apr 16, 2019 (AB Digital via COMTEX) -- Browse 36 market data Tables and 25 Figures spread through 147 Pages and in-depth analysis on Global Opioids Drugs market by Product (Buprenorphine, Fentanyl, ... […]
- New Comprehensive Report on Chronic Pain Treatment Market is Thriving Worldwide with Prominent Players: Pfizer, Medtronic | Forecast to 2023 on April 15, 2019 at 4:47 am
Apr 15, 2019 (Heraldkeeper via COMTEX) -- Global Chronic Pain Treatment Market Report 2019 offers elaborated knowledge on the market parts like size, Key Regions, growth, trends, dominating firms, ... […]
- Costa Mesa files lawsuit against distributors and manufacturers of opioid pain medication on April 12, 2019 at 1:15 am
Costa Mesa is taking distributors and manufacturers of opioid pain medication to court in a bid to recoup tax dollars it alleges were spent as a result of the addiction epidemic that has afflicted ... […]
via Bing News